No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
SLP240816C35000
- 4.70
- -1.20-20.34%
15min DelayClose Jul 22 15:59 ET
5.90High4.70Low
5.90Open5.90Pre Close4 Volume0 Open Interest35.00Strike Price2.12KTurnover57.26%IV-1.15%PremiumAug 16, 2024Expiry Date5.16Intrinsic Value100Multiplier24DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.8460Delta0.0396Gamma6.92Leverage Ratio-0.0327Theta0.0192Rho5.86Eff Leverage0.0249Vega
Intraday
- 5D
- Daily
News
Simulations Plus, Inc. (SLP): One of the Most Profitable Stocks According to Hedge Funds?
JMP Securities Initiates Simulations Plus at Market Perform
Simulations Plus Analyst Ratings
JMP Securities Initiates Simulations Plus(SLP.US) With Hold Rating
Simulations Plus: A Strong Hold Amidst Growth and Strategic Acquisitions
Simulations Plus (SLP) Ties Up With ICCS for Chemical Safety
Comments
Simulations Plus' high P/E ratio is likely due to investor expectations of strong future growth, despite stagnant earnings over the past three years. Investors seem willing to pay a premium for the stock in anticipation of its superior earnings outlook.
Simulations Plus, Inc.'s (NASDAQ:SLP) Share Price Matching Investor OpinionSimulations plus demonstrates efficient use of profits alongside solid earnings growth, but lower ROE compared to industry average is worrisome. Still, analysts predict further earnings growth.
Kenanga Research suggests SLP Resources' performance may continue to struggle due to weak export demand and rising competition. Strong financial position and high-margin products are anticipated to maintain stability, despite Hong Leong Bank's indication of weak demand in Japan, SLP's primary market.
$Abacus Life(ABL.US$ $Ameresco(AMRC.US$ $Applied Digital(APLD.US$ $Caribou Biosciences(CRBU.US$ $Duke Energy(DUK.US$ $EdtechX Acquisition(EDTX.US$ $Genius Sports(GENI.US$ $Gorilla Technology(GRRR.US$ $Joby Aviation(JOBY.US$ $Kazia Therapeutics(KZIA.US$ $Perion Network(PERI.US$ $Pfizer(PFE.US$ $Polestar Automotive(PSNY.US$ $Simulations Plus(SLP.US$ $VBI Vaccines(VBIV.US$
3
1
$Simulations Plus(SLP.US$ Cramer’s lightning round: I can’t recommend Simulations Plus.
3
Read more